HC Wainwright & Co. Reiterates Buy on Biohaven, Maintains $59 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Douglas Tsao has reiterated a Buy rating on Biohaven (NYSE:BHVN) and maintained a $59 price target.
May 30, 2024 | 6:47 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. analyst Douglas Tsao has reiterated a Buy rating on Biohaven and maintained a $59 price target.
The reiteration of a Buy rating and the maintenance of a $59 price target by a reputable analyst can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100